BLUE BIOFUELS, INC. (BIOF) Form 10-Q — May 4, 2026
Blue Biofuels, Inc. reported no revenue for the quarter ended March 31, 2026, remaining in its pre-commercialization stage focused on developing its Cellulose-to-Sugar (CTS) technology. The company recorded a net loss of $663,801 for the quarter, widening from a loss of $243,833 in the prior-year period, primarily due to the absence of government grant income recognized in 2025 and ongoing research and development expenses. Liquidity remains a critical concern, with cash and cash equivalents dropping to $8,665 from $65,200 at the end of 2025.
Key figures
- Revenue
- 0
- Total Debt
- 5246366
- Cash Position
- 8665
- Shares Outstanding
- 320948112
- Net Cash Provided By Financing Activities
- 372000
Price after filing
Close on the filing date to close N calendar days later (from $0.16). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.